Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relx (RELX) Liabilities and Shareholders Equity (2016 - 2025)

Relx (RELX) has disclosed Liabilities and Shareholders Equity for 10 consecutive years, with $19.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 1.06% to $19.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $76.1 billion, a 1.26% increase, with the full-year FY2025 number at $19.6 billion, up 1.06% from a year prior.
  • Liabilities and Shareholders Equity was $19.6 billion for Q4 2025 at Relx, up from $19.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $19.6 billion in Q4 2025 to a low of $18.5 billion in Q4 2023.
  • A 5-year average of $19.0 billion and a median of $18.7 billion in 2021 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: dropped 0.61% in 2022, then grew 4.91% in 2024.
  • Relx's Liabilities and Shareholders Equity stood at $18.7 billion in 2021, then decreased by 0.61% to $18.6 billion in 2022, then dropped by 0.28% to $18.5 billion in 2023, then rose by 4.91% to $19.4 billion in 2024, then grew by 1.06% to $19.6 billion in 2025.
  • Per Business Quant, the three most recent readings for RELX's Liabilities and Shareholders Equity are $19.6 billion (Q4 2025), $19.4 billion (Q4 2024), and $18.5 billion (Q4 2023).